Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2016

Sep 9, 2016

30786_dirs_2016-09-09_cf7419b5-bef9-4ad0-888d-9ca5d430d8eb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-09-07

Reporting Person: GOETZ JOHN (EVP, Chief Operating Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-09-07 Restricted Stock Units $0 A 8000 Acquired Bio-Rad A Common Stock (8000) Direct
2016-09-07 Non-Qualified Stock Option (right to buy) $159.32 A 8000 Acquired 2026-09-07 Bio-Rad A Common Stock (8000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 55867.4199 Direct

Footnotes

F1: Includes 9.280, 53.3856 and 60.8402 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/15, 3/31/16 and 6/30/16, respectively.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.